| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.076 | 0.2 |